The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss

被引:50
作者
Ruban, Aruchuna [1 ]
Ashrafian, Hutan [1 ]
Teare, Julian P. [1 ]
机构
[1] Imperial Coll, Dept Surg & Canc, London, England
关键词
HUMAN GUT MICROBIOTA; GASTRIC BYPASS; BARIATRIC SURGERY; GLYCEMIC CONTROL; BILE-ACIDS; OBESITY; GLUCOSE; MULTICENTER; EFFICACY; MELLITUS;
D O I
10.1155/2018/7823182
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The rapid rise of obesity and type 2 diabetes poses a global threat to healthcare and is a major cause of mortality and morbidity. Bariatric surgery has revolutionised the treatment of both these conditions but is invasive and associated with an increased risk of complications. The EndoBarrier is a device placed endoscopically in the duodenum, which is designed to mimic the effects of gastric bypass surgery with the aim of inducing weight loss and improving glycaemic control. This review outlines the current clinical evidence of the device, its efficacy, potential mechanisms of action, and utility in clinical practice.
引用
收藏
页数:9
相关论文
共 40 条
[21]   Microbial ecology - Human gut microbes associated with obesity [J].
Ley, Ruth E. ;
Turnbaugh, Peter J. ;
Klein, Samuel ;
Gordon, Jeffrey I. .
NATURE, 2006, 444 (7122) :1022-1023
[22]   Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk [J].
Li, Jia V. ;
Ashrafian, Hutan ;
Bueter, Marco ;
Kinross, James ;
Sands, Caroline ;
le Roux, Carel W. ;
Bloom, Stephen R. ;
Darzi, Ara ;
Athanasiou, Thanos ;
Marchesi, Julian R. ;
Nicholson, Jeremy K. ;
Holmes, Elaine .
GUT, 2011, 60 (09) :1214-1223
[23]  
Mraz M., 2014, 75 ANN M AM DIAB ASS
[24]   EndoBarrier®: a Safe and Effective Novel Treatment for Obesity and Type 2 Diabetes? [J].
Patel, Nisha ;
Mohanaruban, Aruchuna ;
Ashrafian, Hutan ;
Le Roux, Carel ;
Byrne, James ;
Mason, John ;
Hopkins, James ;
Kelly, Jamie ;
Teare, Julian .
OBESITY SURGERY, 2018, 28 (07) :1980-1989
[25]   Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism [J].
Patti, Mary-Elizabeth ;
Houten, Sander M. ;
Bianco, Antonio C. ;
Bernier, Raquel ;
Larsen, P. Reed ;
Holst, Jens J. ;
Badman, Michael K. ;
Maratos-Flier, Eleftheria ;
Mun, Edward C. ;
Pihlajamaki, Jussi ;
Auwerx, Johan ;
Goldfine, Allison B. .
OBESITY, 2009, 17 (09) :1671-1677
[26]   The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review [J].
Penney, N. C. ;
Kinross, J. ;
Newton, R. C. ;
Purkayastha, S. .
INTERNATIONAL JOURNAL OF OBESITY, 2015, 39 (11) :1565-1574
[27]   Safety and efficacy of the endoscopic duodenal-jejunal bypass liner prototype in severe or morbidly obese subjects implanted for up to 3 years [J].
Quezada, Nicolas ;
Munoz, Rodrigo ;
Morelli, Carla ;
Turiel, Dannae ;
Hernandez, Julian ;
Pimentel, Fernando ;
Escalona, Alex .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (01) :260-267
[28]   Longitudinal evaluation of efficacy, safety and nutritional status during one-year treatment with the duodenal-jejunal bypass liner [J].
Riedel, Nina ;
Laubner, Katharina ;
Lautenbach, Anne ;
Schon, Gerhard ;
Schlensak, Matthias ;
Stengel, Rainer ;
Eberl, Thomas ;
Dederichs, Frank ;
Aberle, Jens ;
Seufert, Jochen .
SURGERY FOR OBESITY AND RELATED DISEASES, 2018, 14 (06) :769-779
[29]   First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve [J].
Rodriguez-Grunert, Leonardo ;
Neto, Manoel Passos Galvao ;
Alamo, Munir ;
Ramos, Almino Cardoso ;
Baez, Percy Brante ;
Tarnoff, Michael .
SURGERY FOR OBESITY AND RELATED DISEASES, 2008, 4 (01) :55-59
[30]   The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes [J].
Rohde, Ulrich ;
Federspiel, Cecilie A. ;
Vilmann, Peter ;
Langholz, Ebbe ;
Friis, Steffen U. ;
Krakauer, Martin ;
Rehfeld, Jens F. ;
Holst, Jens J. ;
Vilsboll, Tina ;
Knop, Filip K. .
DIABETES OBESITY & METABOLISM, 2017, 19 (02) :189-199